ENDP Endo International plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ENDP

Price (delayed)

$6.85

Market cap

$1.58B

P/E Ratio

8.56

Dividend/share

N/A

EPS

$0.8

Enterprise value

$8.56B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, ...

Highlights

ENDP's net income has surged by 144% year-on-year
The EPS has soared by 143% YoY
The company's quick ratio fell by 16% QoQ

Key stats

What are the main financial stats of ENDP
Market
Shares outstanding
230.5M
Market cap
$1.58B
Enterprise value
$8.56B
Valuations
Price to earnings (P/E)
8.56
Price to book (P/B)
N/A
Price to sales (P/S)
0.54
EV/EBIT
19.32
EV/EBITDA
8.9
EV/Sales
2.95
Earnings
Revenue
$2.9B
EBIT
$442.9M
EBITDA
$961.71M
Free cash flow
$327.42M
Per share
EPS
$0.8
Free cash flow per share
$1.43
Book value per share
-$2.81
Revenue per share
$12.66
TBVPS
$12.92
Balance sheet
Total assets
$9.26B
Total liabilities
$9.91B
Debt
$8.36B
Equity
-$647.94M
Working capital
$1.16B
Liquidity
Debt to equity
-12.91
Current ratio
1.92
Quick ratio
1.51
Net debt/EBITDA
7.26
Margins
EBITDA margin
33.1%
Gross margin
50.3%
Net margin
6.3%
Operating margin
17.4%
Efficiency
Return on assets
2%
Return on equity
N/A
Return on invested capital
5.1%
Return on capital employed
5.5%
Return on sales
15.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENDP stock price

How has the Endo International stock price performed over time
Intraday
-5.26%
1 week
-30.6%
1 month
-20.9%
1 year
26.85%
YTD
-4.6%
QTD
-4.6%

Financial performance

How have Endo International's revenue and profit performed over time
Revenue
$2.9B
Gross profit
$1.46B
Operating income
$506.42M
Net income
$183.94M
Gross margin
50.3%
Net margin
6.3%
ENDP's net income has surged by 144% year-on-year
Endo International's net margin has soared by 143% YoY
The operating margin has soared by 76% since the previous quarter
Endo International's operating income has surged by 75% QoQ

Growth

What is Endo International's growth rate over time

Valuation

What is Endo International stock price valuation
P/E
8.56
P/B
N/A
P/S
0.54
EV/EBIT
19.32
EV/EBITDA
8.9
EV/Sales
2.95
The EPS has soared by 143% YoY
Endo International's equity has increased by 25% YoY and by 17% from the previous quarter
ENDP's price to sales (P/S) is 80% higher than its last 4 quarters average of 0.3 but 10% lower than its 5-year quarterly average of 0.6

Efficiency

How efficient is Endo International business performance
Endo International's ROA has soared by 147% YoY
The ROS has soared by 87% from the previous quarter
Endo International's return on invested capital has surged by 82% QoQ

Dividends

What is ENDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENDP.

Financial health

How did Endo International financials performed over time
The company's total assets is 7% lower than its total liabilities
The current ratio has contracted by 12% from the previous quarter but it has grown by 8% YoY
The debt to equity has contracted by 32% YoY and by 21% from the previous quarter
Endo International's equity has increased by 25% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.